Working Life: Dr Todd Hobbs, Vice President and Chief Medical Officer, Novo Nordisk
April 24, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Working Life, feature, pharma
Novo Nordisk’s VP and CMO discusses his leap from family medicine into the pharma industry, his biggest achievements, and how …
AbbVie’s Skyrizi snatches up FDA approval in moderate to severe plaque psoriasis
April 24, 2019Research and Development, Sales and Marketing AbbVie, FDA, Skyrizi, US, pharma, psoriasis
AbbVie has revealed that its interleukin-23 (IL-23) inhibitor Skyrizi (risankizumab-rzaa) has received marketing authorisation in the US from the FDA …
Eli Lilly sell Chinese rights to two antibiotics in deal worth $375 million
April 24, 2019Research and Development
US firm Eli Lilly has agreed to sell the Chinese rights to two of its antibiotics, Ceclor (cefaclor) and Vancocin …
Former pharma wholesaler execs face criminal charges over opioid crisis
April 24, 2019Research and Development Litigation, RDC, Rochester Drug Cooperative, opioid crisis, opioids
Laurence Doud III, the former CEO of New York-based Rochester Drug Co-operative (RDC) – one of the largest drug distributors …
Teva terminates Ajovy at Phase 3 in episodic cluster headache
April 24, 2019Research and Development Teva, ajovy, headache, pharma
Israeli pharmaceutical firm Teva has announced its intention to terminate further development of its calcitonin gene-related peptide (CGRP) inhibitor Ajovy …
Keytruda/Inlyta combo scores FDA approval in advanced kidney cancer
April 23, 2019Manufacturing and Production, Sales and Marketing FDA, MSD, Pfizer, Sutent, inlyta, keytruda, pharma
MSD’s anti-PD-1 therapy Keytruda (pembrolizumab) has secured another approval from the FDA, this time as a first-line treatment in combination …
J&J pay $9.9 million to settle surgical mesh implant case
April 23, 2019Manufacturing and Production . Johnson & Johnson, J&J, JJ, Johnson & Johnson, Litigation, washington
Healthcare conglomerate Johnson & Johnson has agreed to pay $9.9 million to settle a Washington state lawsuit over the firm’s …
Pfizer immune-oncology leader joins Aduro Biotech as new CMO
April 23, 2019Manufacturing and Production Aduro Biotech, Cancer, Pfizer, immuno-oncology, immunotherapy, oncology
Pfizer’s vice president and head of immune-oncology clinical development has joined Aduro Biotech as the company’s new Chief Medical Officer, …
Signal boosting implant allows patients with Parkinson’s to walk
April 23, 2019Manufacturing and Production Canada, Parkinson's, Western University, electrical signals, implant
Patients with Parkinson’s have been able to walk after receiving electrical stimulation to their spines. A new treatment, developed by …
Innovative malaria vaccine to be trialled in Malawi
April 23, 2019Manufacturing and Production GSK, Mosquirix, RTS S, ghana, kenya, malaria, malawi
An innovative malaria vaccine is set to be trialled in Malawi as part of large scale trials which will see …
Novartis reveals promising interim Phase 3 data for gene therapy Zolgensma in spinal muscular atrophy
April 18, 2019Research and Development Novartis, Zolgensma, pharma
Novartis has revealed new interim data from its Phase 3 trial investigating the efficacy of its gene therapy Zolgensma (onasemnogene …
Top Ten most popular articles on Pharmafile.com this week!
April 18, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Genentech, Gilead, HIV, MS, Novartis, kidney disease, pharma
This week was a good one for clinical trials and a bad one for employees after both Gilead and GSK …
NICE recommends UCB’s Cimzia in severe plaque psoriasis
April 18, 2019Sales and Marketing Cimzia, NICE, UCB Pharma, UK, pharma, plaque psoriasis, psoriasis
NICE has announced its decision to recommend UCB Pharma’s Cimzia (certolizumab pegol) for use on the NHS in England in …
CBD could be used to deliver drugs into the brain, research shows
April 18, 2019Research and Development BBB, CBD, CNS, brain, drug delivery, neuroscience
Cannabidiol (CBD), one of 113 cannabinoids in cannabis plants, could be used to deliver medicines into the brain, according to …
Doctors cure ‘bubble boy syndrome’ using modified version of HIV
April 18, 2019Research and Development HIV, SCID-X1, gene therapy, immunodeficiency, immunology
Doctors at St. Jude Children’s Research Hospital have been able to treat patients with X-linked severe combined immunodeficiency (SCID-X1) – …
Insys Therapeutics names current CFO Andrew Long as company’s new CEO
April 17, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insys Therapeutics, appointment, pharma
Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s new CEO. The opioid drugmaker …
Imperial College London researchers developing tech to monitor dementia patients at home
April 17, 2019Research and Development dementia, imperial college london, pharma
Researchers at Imperial College London are hard at work developing technology to aid the lives of dementia patients in their …
MS Pharma ink deal for acquisition of Genepharm
April 17, 2019Research and Development
Jordanian firm MS Pharma has entered into an agreement to acquire 100% of the outstanding shares of Greek company Genepharm. …
NICE recommends Akcea’s Tegsedi for rare, life-threatening progressive disease
April 17, 2019Research and Development, Sales and Marketing Akcea, NHS, NICE, Tegsedi, UK
Akcea Therapeutics has shared the news that Tegsedi (inotersen), its antisense oligonucleotide (ASO) inhibitor of human transthyretin (TTR) production, has …
China introduces new laws to ensure steady supply of drugs
April 17, 2019Research and Development China, National Health Commission, laws, markets, pharma, regulation
China’s National Health Commission (NHC) has said it will monitor the country’s drugs market more closely in order to ensure …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
